Roka Bioscience, Inc. (ROKA)

[MAK517]

Stay away from this stock. SEC Filing Schedule 14A page 4 "Our current estimate is that there will be between $2.3 million and $5.0 million, or $0.45 to $0.99 per share of our common stock, available for distribution over time to our stockholders"

[MAK517]

Not sure what you are talking about.
The proxy statement has been filed and voted on and voted for.
All matters are settled per the proxy statement voting items.
There is no more "merger" "white knight" or other 3rd party to come into the situation.

[MAK517]

ROKA is selling all assets.
Proxy statements says a max payout will be $0.99/share from the proceeds.
This represents the initial payout.
The final payout will be 3 yrs later if there are any funds remaining after all expenses and legal matters (lawsuits).

[willlbone]

RoadKill.

[Atlanta1]

It depends on what they can get for the assets.

If it's not an arm's length transaction, the ROKA shareholders get screwed.

The banks/lenders get made whole first.

[baywolf415]

what exactly does this mean?

1) 1. The stockholders approved a proposal to adopt the Asset Purchase Agreement, dated as of August 16, 2017, by and among
the Company and Rokabio, Inc. (the “Buyer”), a newly formed subsidiary of Institute for Environmental Health (“IEH” or the “Parent”)
and as such agreement may be amended from time to time (the “Asset Sale Proposal”

2)Item 8.01. Other Events
The Company expects to close the sale of substantially all of its assets to the Buyer pursuant to the terms of the Asset Purchase
Agreement on or about November 1, 2017. Following the closing of the asset sale, in accordance with the terms of the Asset Purchase
Agreement, the Company will provide certain transition services to the Buyer during the Transition Period (as defined in the Asset
Purchase Agreement).
Forward-Looking Information

the way i read it is that starting 11-1-2017 all of ROKAS assets will be sold to the newly formed Subsidiary "IEH" A company of ROKA.

so roka is getting rid of all of their assets ? meaning they will be worthless ??? is that the reason why the stock is going down???

this comes from the latest 8-k filling

http://rokabio.investorroom.com/sec-filings

[Atlanta1]

the news looks like a death sentence for $ROKA

[Oger]

Yes. I wanna know too! What news??

[Atlanta1]

What "pending news looming"?

[Cappello]

Could see a test of the 2.50 resistance range especially with pending news looming. Would be nice to see the three we all have been looking for.

[cjstocksup]

Yep ROKA had a crazy day.

[TheFinalCD]

ROKA

[ClayTrader]

* * $ROKA Video Chart 10-25-17 * *

Link to Video - click here to watch the technical chart video

[Trons]

$5 on the horizon with news

[Atlanta1]

already traded almost 2X the float today?


this afternoon should be interesting.

$ROKA

[Cappello]

Just the start, pipeline of news coming, earnings in a couple of weeks, many catalyst to take ROKA past the 2.50 resistance level, good trading to all.

[Trons]

Alive again. going over $2

[Atlanta1]

trading temporarily halted

[Trons]

Short squeeze today, going to ride high!

[e-ore]

Nice payday for Painter. Buy for $300,000 or so, hold 2 weeks, sell for $500,000.

[Atlanta1]

uh oh - Painter sold all shares

[yaadmon]

Exactly, still waiting for 3's....just consolidation after what was a nice breakout

[Cappello]

News is coming, earnings upside projected and the possibility of M&A activity, expect an early in the week run. Once through 2.50 Three is on the table then.

[Atlanta1]

took a flyer avg. sub $1.68

$ROKA

[Jacob76]

Roka got alerted by tons of groups before the close. Will be a great Monday easily hitting 3.00!

[ClayTrader]

* * $ROKA Video Chart 10-12-17 * *

Link to Video - click here to watch the technical chart video

[TrendTrade2016]

lets fly to ROKA Baton!

[MWM]

Finally moving! Luckily I averaged down at $1.65 yesterday, painful hold for the last 48 hours lol!

[aristotelisonassis]

short this is crazy. Long here!

[MWM]

i averaged down this AM, ready for another Big Move!

[cjstocksup]

No idea but let's see the $3.00 mark break today.

[biotechnician]

So where do you think ROKA can go to? The charts are extremely bullish and last year traded at $16.

[jakewhite]

Ready for round 2

[MWM]

Nice!

[jakewhite]

Got in at $1.43 and unloaded 2.40

[omri]

Me too st that same price !!!! Gltu $$$$$

[ClayTrader]

* * $ROKA Video Chart 10-10-17 * *

Link to Video - click here to watch the technical chart video

[cjstocksup]

The acquisition news is everywhere on some sites they have the wrong company listed as the buyer. It will get figured out n the days ahead. This company A2A Pharmaceuticals is private now trying to go public based on the news we have on the shares purchased. It is the SS that is attractive for a run over $3.00 and $5.00 ahead on solid buying pressure in the days ahead. Today was too many inexperienced traders and algorithm day traders who messed us up because none of them are sued to low OS and low float stocks like ROKA.

[MWM]

Trading nicely in A/H now...

[cjstocksup]

I bought 40K shares today total. Since we had so much crazy trading today we should run up smoother tomorrow for that first $3.00 break above IMO.

[MWM]

Added more, going to be a big open in the Morning, not sure why they are sitting on it for the close!

[MWM]

There is no float here, only scalpers making nickles! Big move coming into the close imo!

[getoffyourass]

Here comes the breakout

[MWM]

Looking for a BIG close! under $2 is a DEAL!

[cjstocksup]

ROKA OS 5 million shares Float approx 2 million shares.

[cjstocksup]

This is why ROKA should be at a new HOD in the next hour easy and could easily close over $3.00.
Roka Bioscience (ROKA) surged 153% to their highest level in more than two months -- piercing their 50- and 100-day moving averages for the first time since April -- in the wake of a disclosure Edward Painter, CEO of A2A Pharmaceuticals, has acquired 340,000 shares of Roka, or 6.79%. "Edward Painter purchased shares with the intention of seeking a business combination with A2A Pharmaceuticals, a private biotechnology company," according to a regulatory statement. "He may sell shares or buy additional shares or change his purpose of transacting in the future." Roka sold substantially all of its assets in August to a subsidiary of Institute for Environmental Health for $17.5 million in cash, the initial step in a contemplated liquidation of the molecular diagnostics company.

[MWM]

Orbimed Advisors Llc Sells 474,676 Shares of Roka Bioscience, Inc. (ROKA) Stock
Posted by Amber O'Connor on Oct 4th, 2017

Roka Bioscience logoRoka Bioscience, Inc. (NASDAQ:ROKA) major shareholder Orbimed Advisors Llc sold 474,676 shares of the stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $0.72, for a total value of $341,766.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Orbimed Advisors Llc also recently made the following trade(s):
On Wednesday, September 27th, Orbimed Advisors Llc sold 127,601 shares of Roka Bioscience stock. The shares were sold at an average price of $0.98, for a total value of $125,048.98.
On Wednesday, August 23rd, Orbimed Advisors Llc sold 1,100 shares of Roka Bioscience stock. The shares were sold at an average price of $1.50, for a total value of $1,650.00.
On Thursday, August 24th, Orbimed Advisors Llc sold 14,300 shares of Roka Bioscience stock. The shares were sold at an average price of $1.50, for a total value of $21,450.00.
On Tuesday, August 22nd, Orbimed Advisors Llc sold 75,276 shares of Roka Bioscience stock. The shares were sold at an average price of $1.52, for a total value of $114,419.52.
Roka Bioscience, Inc. (NASDAQ ROKA) opened at 0.67 on Wednesday. The company has a 50 day moving average price of $1.16 and a 200 day moving average price of $2.54. The firm’s market capitalization is $3.35 million. Roka Bioscience, Inc. has a 12 month low of $0.66 and a 12 month high of $8.50.

An institutional investor recently raised its position in Roka Bioscience stock. Sabby Management LLC boosted its holdings in Roka Bioscience, Inc. (NASDAQ:ROKA) by 6.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 389,136 shares of the medical research company’s stock after purchasing an additional 23,916 shares during the quarter. Sabby Management LLC owned about 7.77% of Roka Bioscience worth $1,374,000 at the end of the most recent quarter. 66.51% of the stock is owned by institutional investors.

Roka Bioscience Company Profile
Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

[MWM]

And there are our sellers, later fellas, great trade lol!

[MWM]

* Orbimed Advisors LLC cuts stake in Roka Bioscience to 10.24 percent as of Oct 3 from a stake of 13.86 percent as of Sept 28 - SEC filing Source text for Eikon: Further company coverage:

Oct 5 (Reuters) - Roka Bioscience Inc:

[MWM]

I think this looks like a Volcano erupting extremely soon, The Volume is out of control! I seriously pray there are some shorts sitting around in this.